Skip to content
New issue

Have a question about this project? Sign up for a free GitHub account to open an issue and contact its maintainers and the community.

By clicking “Sign up for GitHub”, you agree to our terms of service and privacy statement. We’ll occasionally send you account related emails.

Already on GitHub? Sign in to your account

[NTR/TFAP2B] #8256

Closed
elliebroeren opened this issue Oct 17, 2024 · 4 comments · Fixed by #8637
Closed

[NTR/TFAP2B] #8256

elliebroeren opened this issue Oct 17, 2024 · 4 comments · Fixed by #8637
Assignees
Labels

Comments

@elliebroeren
Copy link

Preferred gene-related syndrome label
TFAP2B-related PDA and Char syndrome spectrum disorder

Synonyms

Parent term (use OLS, or your favorite ontology browser)
MONDO:0005453

Definition
Any congenital heart disease caused by pathogenic mutations in the TFAP2B gene, which encodes the transcription factor AP-2β. Two overlapping clinical presentations have been associated with TFAP2B mutations; Char syndrome (MIM:169100) and Patent ductus arteriosus 2 (MIM:617035). These phenotypes have been grouped together into one disease entity: TFAP2B - related PDA and Char syndrome spectrum disorder. This disorder is characterized by patent ductus arteriosus, facial dysmorphism and hand anomalies (Orphanet). Additional features include sensorineural hearing loss, scoliosis, dental anomalies, and central diabetes insipidus (PMID: 31012281). Given the spectrum of symptoms associated with this condition, patients may exhibit a combination of these features. The underlying mechanism of the spectrum disorder is both dominant negative and loss-of-function. Pathogenic missense variants reported in Char syndrome patients appear to be dominant negative while loss-of-function alleles in PDA patients are likely to act through haploinsufficiency (GeneReviews).

Definition source
PMID: 31012281

Your nano-attribution (ORCID) or URL for a working group
If you don't have an ORCID, you can sign up for one here

@sabrinatoro sabrinatoro added user request A request from an external user curateathon2024 labels Nov 6, 2024
@katiermullen katiermullen self-assigned this Nov 13, 2024
@katiermullen
Copy link
Collaborator

@elliebroeren Thank you for this new term request!

In reviewing the terms in Mondo, there currently exists the term, MONDO:0008209 'Char syndrome' defined as 'Char syndrome is characterized by the triad of patent ductus arteriosus (PDA), facial dysmorphism and hand anomalies.' From Orphanet:46627.

This term is the child of:

  • 'has material basis in germline mutation in' some TFAP2B
  • 'multiple congenital anomalies/dysmorphic syndrome-variable intellectual disability syndrome'
  • 'patent ductus arteriosus'
  • 'syndromic disease'

Does this term suit your needs? If so, we can add the synonym 'TFAP2B-related PDA and Char syndrome spectrum disorder' if you could kindly provide your ORCID or another source for this synonym.

Thank you!

@elliebroeren
Copy link
Author

elliebroeren commented Nov 13, 2024 via email

@katiermullen
Copy link
Collaborator

Hi @elliebroeren,

Thank you for your speedy reply!

I am mentioning @sabrinatoro here to make sure she is in agreement.

In Mondo, we would annotate patients with the full Char syndrome using MONDO:0008209 'Char syndrome'. Those patients with only PDA could be classified as having MONDO:0014878 'patent ductus arteriosus 2' that 'has material basis in germline mutation in' some TFAP2B.

Can we have one clin gen term map to two Mondo terms?

@katiermullen
Copy link
Collaborator

Update - we need to consider making a pattern for these spectrum disorders.

Could this term be called 'TFAP2B-related congenital heart disease spectrum disorder'?

  • Add clin gen label: TFAP2B-related PDA and Char syndrome spectrum disorder
  • Def: Any congenital heart disease caused by pathogenic variation(s) in the TFAP2B gene, which encodes the transcription factor AP-2β. This disorder is characterized by patent ductus arteriosus, facial dysmorphism and hand anomalies (Orphanet). Additional features include sensorineural hearing loss, scoliosis, dental anomalies, and central diabetes insipidus (PMID: 31012281). Given the spectrum of symptoms associated with this condition, patients may exhibit a combination of these features. The underlying mechanism of the spectrum disorder is both dominant negative and loss-of-function. Pathogenic missense variants reported in Char syndrome patients appear to be dominant negative while loss-of-function alleles in PDA patients are likely to act through haploinsufficiency (GeneReviews).
  • Comment: Two overlapping clinical presentations have been associated with TFAP2B mutations; Char syndrome (MIM:169100) and Patent ductus arteriosus 2 (MIM:617035). These phenotypes have been grouped together into one disease entity: TFAP2B - related PDA and Char syndrome spectrum disorder [Clin Gen].

katiermullen added a commit that referenced this issue Jan 30, 2025
Sign up for free to join this conversation on GitHub. Already have an account? Sign in to comment
Labels
Projects
None yet
Development

Successfully merging a pull request may close this issue.

3 participants